Literature DB >> 1987791

Body composition and metabolic rate in rat during a continuous infusion of cachectin.

E Hoshino1, C Pichard, C E Greenwood, G C Kuo, R G Cameron, R Kurian, J P Kearns, J P Allard, K N Jeejeebhoy.   

Abstract

Changes in brain metabolites, energy balance, resting metabolic rate, body composition, and organ histology were studied over 10 days in control (C), cachectin-infused (CIR), and pair-fed (PFR) (in relation to CIR) rats. The cachectin was continuously infused for the 10 days into the superior vena cava at the rate of approximately 100 micrograms.kg-1.day-1. The brain of the CIR had significantly more tryptophan and 5-hydroxyindole-3-acetic acid than C and PFR. The CIR rats were anorexic, hypermetabolic, relatively hyperglycemic, and had raised blood urea nitrogen with comparable creatinine levels when compared with similarly wasted PFR. They had significant loss of muscle mass, especially in muscles with a predominance of type II fibers. However they gained liver, heart, and lung mass. The loss of muscle mass could be ascribed to dietary deficiency, but the gain in visceral mass was associated with an increase in organ DNA and protein. Histology showed that there was cell proliferation in the liver, heart, and kidneys. The data are consistent with centrally mediated anorexia with nutritionally mediated muscle wasting but with visceral hypermetabolism, protein accumulation, and cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1987791     DOI: 10.1152/ajpendo.1991.260.1.E27

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

Review 1.  Molecular inflammation: underpinnings of aging and age-related diseases.

Authors:  Hae Young Chung; Matteo Cesari; Stephen Anton; Emanuele Marzetti; Silvia Giovannini; Arnold Young Seo; Christy Carter; Byung Pal Yu; Christiaan Leeuwenburgh
Journal:  Ageing Res Rev       Date:  2008-07-18       Impact factor: 10.895

2.  Frailty syndrome and skeletal muscle: results from the Invecchiare in Chianti study.

Authors:  Matteo Cesari; Christiaan Leeuwenburgh; Fulvio Lauretani; Graziano Onder; Stefania Bandinelli; Cinzia Maraldi; Jack M Guralnik; Marco Pahor; Luigi Ferrucci
Journal:  Am J Clin Nutr       Date:  2006-05       Impact factor: 7.045

3.  Energy expenditure and body composition in children with Crohn's disease: effect of enteral nutrition and treatment with prednisolone.

Authors:  M Azcue; M Rashid; A Griffiths; P B Pencharz
Journal:  Gut       Date:  1997-08       Impact factor: 23.059

4.  Effect of tumor necrosis factor-alpha on triglyceride and phospholipid content and fatty acid composition of liver and carcass in rats.

Authors:  N Raina; J Matsui; S C Cunnane; K N Jeejeebhoy
Journal:  Lipids       Date:  1995-08       Impact factor: 1.880

5.  Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation.

Authors:  R Roubenoff; R A Roubenoff; J G Cannon; J J Kehayias; H Zhuang; B Dawson-Hughes; C A Dinarello; I H Rosenberg
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

Review 6.  Target population for clinical trials on sarcopenia.

Authors:  M Cesari; M Pahor
Journal:  J Nutr Health Aging       Date:  2008 Aug-Sep       Impact factor: 4.075

7.  Role of Sphingosine 1-Phosphate Signalling Axis in Muscle Atrophy Induced by TNFα in C2C12 Myotubes.

Authors:  Caterina Bernacchioni; Veronica Ghini; Roberta Squecco; Eglantina Idrizaj; Rachele Garella; Elisa Puliti; Francesca Cencetti; Paola Bruni; Chiara Donati
Journal:  Int J Mol Sci       Date:  2021-01-28       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.